Create your account

Analyse episodes, create alerts, spot trends before they go mainstream

Already have an account? Sign in

Companies

Bayer

Mentioned in 16 analyzed podcast episodes across 10 shows

German multinational conglomerate and major pharmaceutical/agricultural company that acquired Monsanto for $69 billion in 2017, gaining ownership of Roundup (glyphosate). The company has faced billions in litigation settlements over cancer lawsuits linked to glyphosate exposure and has pursued legal immunity strategies to shield itself from future liability. Podcasts discuss Bayer in contexts ranging from environmental and health advocacy concerns to its involvement in Trump administration policies and its adoption of AI technologies in pharmaceutical R&D.

Episode Mentions

Culture Apothecary with Alex Clark

Culture Apothecary with Alex Clark · Apr 10, 2026

The Biohacker’s Guide To Sleep, Nicotine, & Weight Loss | Dave Asprey

Criticized for acquiring Monsanto and harmful legal practices against farmers; subject of planned Supreme Court rally

Bulletproof Coffee and MCT Oil Weight Loss MechanismOxalate Toxicity and Plant-Based Diet RisksCircadian Rhythm Optimization Through Light Control
View Analysis
Bannon`s War Room

Bannon`s War Room · Apr 3, 2026

Episode 5270: Search For The Pilot Continues; Battle For The Schools In Texas

Owner of Monsanto; Trump administration's solicitor general siding with company on glyphosate federal preemption despite health concerns

Iran Nuclear Negotiations and Military StrategyIllegal Immigration and Sanctuary City PoliciesBond Market Yields and Fiscal Deficit Spending
View Analysis
Decoded | Unlock The Secrets of Human Behavior, Emotion and Motivation

Decoded | Unlock The Secrets of Human Behavior, Emotion and Motivation · Mar 26, 2026

Why Modern Healthcare Keeps You Sick with Dr. Josh Axe

Acquired Monsanto; now responsible for glyphosate products; subject of regulatory scrutiny under RFK Jr.'s HHS leadership

Functional and Cellular Medicine ProtocolsGut Microbiome and SIBO ManagementMast Cell Activation Syndrome (MCAS) and Histamine Intolerance
View Analysis
All Things Sustainable

All Things Sustainable · Mar 13, 2026

Why major companies are backing product-level carbon accounting

Pharmaceutical and life sciences company that joined Carbon Measures coalition

Product-level carbon accountingCarbon intensity standardsLedger-based carbon tracking
View Analysis
Candace

Candace · Mar 9, 2026

Donald Trump Has Betrayed America. | Candace Ep 308

Manufactures glyphosate and white phosphorus; Trump executive order boosted production for military munitions

Occult Symbolism in Political LeadershipCharlie Kirk Assassination Conspiracy TheoriesTrump Administration Foreign Policy and Israel Relations
View Analysis
Consider This from NPR

Consider This from NPR · Feb 27, 2026

Why is MAHA mad at Trump?

Manufacturer of Roundup/glyphosate facing billions in litigation settlements and Supreme Court case on EPA regulatory authority and liability preemption

Glyphosate Regulation and Safety DebateMake America Healthy Again (MAHA) MovementEPA vs. International Agency for Research on Cancer (IARC) Standards
View Analysis
Breaking Points with Krystal and Saagar

Breaking Points with Krystal and Saagar · Feb 26, 2026

2/26/26: Trump Humiliates MAHA RFK Jr, Hakeem Caught Funneling AIPAC Money, AI Midterm Wars Breakout

Owner of Monsanto; Trump administration using Defense Production Act to mandate Roundup production despite RFK Jr.'s previous lawsuit

MAHA Surgeon General Confirmation HearingCasey Means Conflicts of Interest and Product EndorsementsVaccine Skepticism and Medical Misinformation
View Analysis
Knowledge Fight

Knowledge Fight · Feb 23, 2026

#1119: February 21, 2026

Trump signed executive order boosting glyphosate production and protecting Bayer as national security priority despite cancer lawsuit settlements.

Epstein Files Analysis and Human Trafficking AllegationsTrump Administration Epstein Cover-Up ClaimsHoward Lutnick 9/11 Insider Trading Accusations
View Analysis
Marketplace All-in-One

Marketplace All-in-One · Feb 17, 2026

Why would the Fed loosen mortgage regulations?

German conglomerate agreed to pay $7B over 21 years to settle Roundup cancer lawsuit claims

Federal Reserve Mortgage Regulation ReformBank Capital Requirements and Mortgage LendingNon-Bank Fintech Competition in Mortgage Market
View Analysis
Marketplace

Marketplace · Feb 17, 2026

Why would the Fed loosen mortgage regulations?

German conglomerate agreed to pay $7B over 21 years to settle Roundup cancer lawsuit claims

Federal Reserve Mortgage Regulation ReformBank Capital Requirements and Mortgage LendingNon-Bank Mortgage Origination Market Share
View Analysis
Culture Apothecary with Alex Clark

Culture Apothecary with Alex Clark · Feb 17, 2026

Cancer, Cover-Ups & Chemical Immunity: Inside the Monsanto Papers with R. Brent Wisner, Esq

Acquired Monsanto for $69 billion in 2017; now pursuing legal immunity strategies and state-level liability shield laws to prevent future lawsuits

Glyphosate health effects and cancer causationMonsanto internal documents and cover-up evidenceEPA regulatory capture and corruption
View Analysis
Just Ingredients

Just Ingredients · Feb 9, 2026

212 - What’s in Your Food, and Who’s Fighting to Change It

Major pesticide company facing lawsuits over glyphosate-linked cancer cases and lobbying for industry immunity

Artificial food dyes regulation and school lunch policyPesticide restrictions and no-spray zones around schoolsMenstrual product ingredient labeling and heavy metals disclosure
View Analysis
DarkHorse Podcast

DarkHorse Podcast · Jan 7, 2026

Round ‘Em Up! The 308th Evolutionary Lens with Bret Weinstein and Heather Heying

Current owner of Monsanto, inherited litigation liabilities from glyphosate lawsuits and faces EPA re-certification review in 2026.

Glyphosate Safety and Toxicology RetractionGhost Authorship in Scientific PublishingUndisclosed Conflicts of Interest in Toxicology Research
View Analysis
The AI in Business Podcast

The AI in Business Podcast · Jan 7, 2026

Reducing R&D Cycle Time in Pharma Without Increasing Regulatory Risk - with Vaithi Bharath of Bayer

Vaithi Bharath is Associate Director of Data Science and AI Solutions; company implementing AI workflows in clinical R&D

Clinical R&D cycle time reductionPharma data integration and ETL pipelines21 CFR Part 11 compliance and e-signatures
View Analysis
This Podcast Will Kill You

This Podcast Will Kill You · Jul 1, 2025

Ep 180 Food Dyes: It’s all marketing

Started as a coal-tar dye company before pivoting to pharmaceutical production, including aspirin development

FDA food dye regulation and batch certification requirementsSynthetic vs. natural food colorant safety profilesCoal-tar dye history and industrial chemistry origins
View Analysis
Big Ideas Lab

Big Ideas Lab · Feb 25, 2025

Drug Discovery

Historical reference: released over-the-counter aspirin in 1915, marking milestone in drug commercialization

Drug discovery acceleration using high-performance computingMachine learning and AI in molecular designActive learning and automated laboratory feedback loops
View Analysis